Key Developments

On March 7, 2024, Hindustan Syringes & Medical Devices Ltd, a medical device company, launched dispojeket single use syringes to reduce the prevalence of accidental needle stick injuries (NSIs) among health workers, reduction of infections
In September 2022, BD, a medical technology company, announced that it had launched prefillable syringes that set a new standard in performance for vaccine prefillable syringes with new and tightened specifications for processability, cosmetics, contamination, and integrity
In January 2022, ICU Medical Inc., a medical technology company, announced that it had completed its acquisition of Smiths Medical, which manufactures medical devices, from Smiths Group plc., a medical device company. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products.
In April 2021, Hindustan Syringes & Medical Devices Ltd, a medical device company, announced that it had invested US$ 1,000 million to expand its syringe product portfolio. This investment accelerates the syringe production capacity from 2.5 billion syringes to over 3 billion during the ongoing COVID-19 vaccination drive in India.